Condition: Gastro Esophageal Reflux · Sponsor: IRCCS San Raffaele
This observational registry aims to: 1) record the TIF interventions in patients with esophageal or extra-esophageal symptoms; 2) to monitor the therapy response through the clinical experience in terms of effect on the use and dosage of proton pump inhibitors (PPIs) and on the GERD-Health Related Quality of Life (HRQL) and Reflux Symptom Index (RSI) questionnaires scores; 3) to characterize the treated patients population and the predictive factors of TIF success, identifying the subpopulation who may effectively benefit from TIF.
This description comes directly from the study's public registry record.
Pier Alberto Testoni, MD, Prof. · +39 02/26432756 · testoni.pieralberto@hsr.it
Sabrina Gloria Giulia Testoni, MD, PhD · +39 02/26436303 · testoni.sabrinagloriagiulia@hsr.it
Always discuss trial participation with your own doctor first.
| IRCCS San Raffaele | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05066594